Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors.
about
Newer generation antidepressants for depressive disorders in children and adolescentsSelective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescentsSelective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety reviewAssociation between mortality from suicide in England and antidepressant prescribing: an ecological studyComparative efficacy and tolerability of first-generation and newer-generation antidepressant medications for depressive disorders in children and adolescents: study protocol for a systematic review and network meta-analysisThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmShould the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned?Depression, suicidality and antidepressants: A coincidence?Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study.Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in The Health Improvement Network (THIN).Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: a systematic review of published randomized controlled trials.How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?The Food and Drug Administration's deliberations on antidepressant use in pediatric patients.A qualitative study exploring how GPs decide to prescribe antidepressants.Antidepressant therapy in severe depression may have different effects on ego-dystonic and ego-syntonic suicidal ideation.Antidepressants and suicide: what is the balance of benefit and harm.Reflections on relevance: Psychotherapy and Psychosomatics in 2004.Recent developments in health law.Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family.Antidepressants and suicidal behavior in bipolar disorder.Is depression a chronic illness? A sociological perspective.Depression in young people: description, assessment and evidence-based treatment.New-generation antidepressants, suicide and depressed adolescents: how should clinicians respond to changing evidence?Suicidal ideation during antidepressant treatment: do genetic predictors exist?An update on antidepressant use and suicidality in pediatric depression.Oxymoronic or synergistic: deconstructing the psychiatric and/or mental health nurse.Methodological issues in clinical trials of antidepressant medications: perspectives from psychotherapy outcome research.Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes.NICE guidelines for the management of depressionRecurrence of suicidal ideation due to treatment with antidepressants in anxiety disorder: a case report.Antidepressants reduce the risk of suicide among elderly depressed patients.Anticonvulsants and suicide attempts in bipolar I disorders.The intellectual crisis of psychiatric research.Suicidal ideation and depressive mixed states.Increased recognition of depression in primary care. Comparison between primary-care physician and ICD-10 diagnosis of depression.Patient-Centered Perspectives on Antidepressant Use
P2860
Q24202873-1016775D-A2D7-4B4B-8ED3-253B471BC3F3Q24244127-47A2E45E-4E56-4F2C-960E-B974909EAA94Q24556640-EB8A8EBA-3C39-48D8-A8EE-64B57637BA7CQ24803753-9D9FED34-9922-427A-B7E9-6CCB624E782BQ26782153-3199F53C-E593-4FC8-8618-1522BEFC3920Q28066714-93922715-6685-4149-9366-DCE3BF7D099FQ28279067-517F45F1-A086-4948-B5EC-7513F4497DB8Q33671068-974A8824-6D08-4054-8AD9-AC095ACE4A2FQ33853140-5DFD3C04-57EC-40E1-A43C-5DF5A8E7A754Q34200603-04164A38-DA63-4A2F-9C8C-CBD9EEE600D2Q34353845-811BF6CD-24B1-4BEC-A1B4-985776B23197Q34575698-6EB5A204-0148-4A77-927C-4C03E95D9744Q34998784-914191A4-CD54-45F3-ACE8-605CC0F0FCCCQ35021289-C60B7F2B-EDB4-4588-8B22-47B113E11439Q35070463-864FDD17-2713-44D2-8DC9-89087C6DE8A3Q35615293-958A7C34-FE3E-4B4E-B5B4-2B37F8B0EA22Q35997740-33A69A52-4B33-4772-9ADC-E3F685893096Q36150103-F0CDFA59-1E31-4E26-9864-12FC08C9EF01Q36441503-65357C5B-B5B2-49BD-807F-969E0FFB9C8FQ36624146-B2AA6A00-5FC0-461A-8E15-A238ACD4C729Q36669355-8916B6BE-4EB9-40E0-8D91-93DCB93F03DDQ36974391-832E400A-C320-4FEB-B653-80AB68617125Q37157631-54037356-A78F-49ED-A9AA-4D442383E510Q37885976-839D9F2D-4E69-4CC6-B00B-2E35518E155BQ38044018-EA3D66A5-2044-4263-8F48-CDE7878F703DQ38052144-49A985A1-35B7-4947-B311-BF611A674A57Q40457418-C1AB3AEE-42D5-4E50-A8DA-E0007BC00301Q42606458-916D0BC0-A1DF-42DD-A3E8-2AF46884AB79Q42789184-E54DD01A-704D-464D-AAE1-896DC4633B6DQ42912889-42D2DC21-10FD-4CB4-9B8A-02054B2473B8Q46670487-5901F130-A429-4A3D-A0F5-2A5A8A677AE5Q47971188-D1EB6034-5107-48C9-AF49-426F4C06C371Q51915836-4E2E0D05-F92B-46D9-9D46-C0C4C95E5DEFQ51934358-0A93E05C-6635-4AF2-B785-602CDD43AC53Q51971729-8D25A74E-7095-41AD-B5A5-48EF834C48E3Q58034108-44980FB0-C322-40E4-A9BD-1A10A1010A68
P2860
Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors.
@ast
Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors.
@en
Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors.
@nl
type
label
Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors.
@ast
Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors.
@en
Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors.
@nl
prefLabel
Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors.
@ast
Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors.
@en
Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors.
@nl
P921
P356
P1476
Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors.
@en
P356
10.1159/000068691
P50
P577
2003-03-01T00:00:00Z